Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Verschueren

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Rheumatology|November 16, 2020
Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden?Sofia Pazmino, Anikó Lovik, Annelies Boonen, et al.
RMD Open|May 7, 2020
One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatmentKristien Van der Elst, Patrick Verschueren, Diederik De Cock, et al.
BMC Rheumatology|July 21, 2025
Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world dataDelphine Bertrand, Elias De Meyst, Michaël Doumen, et al.
Arthritis and Rheumatism|December 1, 2007
Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolonePatrick Durez, Jacques Malghem, Adrien Nzeusseu Toukap, et al.
RMD Open|November 17, 2024
Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritisPatrick Vandormael, Sukayna Fadlallah, Pieter Ruytinx, et al.
Autoimmunity Reviews|February 11, 2025
ABCE1: A new cytoplasmic autoantibody target in systemic sclerosis-associated interstitial lung diseaseJean-Baptiste Vulsteke, Jan Lenaerts, Doreen Dillaerts, et al.
Rheumatology (Oxford, England)|November 14, 2019
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesAntoine Vanier, Josef S Smolen, Cornelia F Allaart, et al.
Frontiers in Immunology|February 16, 2023
Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritisKaren Yu, Luna Dillemans, Mieke Gouwy, et al.
Rheumatology (Oxford, England)|March 4, 2009
Belgian rheumatologists' perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteriaElke Geens, Piet Geusens, Johan Vanhoof, et al.
Rheumatology and Therapy|September 25, 2023
Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid ArthritisAlejandro Balsa, Siegfried Wassenberg, Yoshiya Tanaka, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|November 16, 2020
Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden?Sofia Pazmino, Anikó Lovik, Annelies Boonen, et al.
RMD Open|May 7, 2020
One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatmentKristien Van der Elst, Patrick Verschueren, Diederik De Cock, et al.
BMC Rheumatology|July 21, 2025
Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world dataDelphine Bertrand, Elias De Meyst, Michaël Doumen, et al.
Arthritis and Rheumatism|December 1, 2007
Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolonePatrick Durez, Jacques Malghem, Adrien Nzeusseu Toukap, et al.
RMD Open|November 17, 2024
Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritisPatrick Vandormael, Sukayna Fadlallah, Pieter Ruytinx, et al.
Autoimmunity Reviews|February 11, 2025
ABCE1: A new cytoplasmic autoantibody target in systemic sclerosis-associated interstitial lung diseaseJean-Baptiste Vulsteke, Jan Lenaerts, Doreen Dillaerts, et al.
Rheumatology (Oxford, England)|November 14, 2019
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesAntoine Vanier, Josef S Smolen, Cornelia F Allaart, et al.
Frontiers in Immunology|February 16, 2023
Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritisKaren Yu, Luna Dillemans, Mieke Gouwy, et al.
Rheumatology (Oxford, England)|March 4, 2009
Belgian rheumatologists' perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteriaElke Geens, Piet Geusens, Johan Vanhoof, et al.
Rheumatology and Therapy|September 25, 2023
Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid ArthritisAlejandro Balsa, Siegfried Wassenberg, Yoshiya Tanaka, et al.
Pageof 16